EDGAR Filing Documents for 0001654954-17-009357

Form 8-K - Current report:

SEC Accession No. 0001654954-17-009357

Filing Date

2017-10-12

Accepted

2017-10-12 15:00:40

Documents

Period of Report

2017-10-10

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	CURRENT REPORT	gtbp_8k.htm	8-K	26014
2	PRESS RELEASE	gtbp_ex991.htm	EX-99.1	8835
	Complete submission text file	0001654954-17-009357.txt		36278

Mailing Address 100 SOUTH ASHLEY DRIVE SUITE 600 TAMPA FL 33602

Business Address 100 SOUTH ASHLEY DRIVE SUITE 600 TAMPA FL 33602 (800) 304-9888

GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)